{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:20:00Z","timestamp":1794410400403,"version":"4.9.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009410","name":"Universitat de Lleida","doi-asserted-by":"publisher","award":["FI-SDUR 2023"],"award-info":[{"award-number":["FI-SDUR 2023"]}],"id":[{"id":"10.13039\/501100009410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","award":["2021-SGR 00323"],"award-info":[{"award-number":["2021-SGR 00323"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2023\\u2013148128OB-I00"],"award-info":[{"award-number":["PID2023\\u2013148128OB-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PDC2021\\u2013120758-I00"],"award-info":[{"award-number":["PDC2021\\u2013120758-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2020\\u2013118296RB-I00"],"award-info":[{"award-number":["PID2020\\u2013118296RB-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia Agency for Administration of University and Research Grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["CPP2021\\u2013008554"],"award-info":[{"award-number":["CPP2021\\u2013008554"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118553","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:00:45Z","timestamp":1758582045000},"page":"118553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Leriglitazone improves iron homeostasis and ferroptotic markers in frataxin-deficient dorsal root ganglia neurons"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-9801","authenticated-orcid":false,"given":"Marta","family":"Portillo-Carrasquer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-0581","authenticated-orcid":false,"given":"Arabela","family":"Sanz-Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-5537","authenticated-orcid":false,"given":"Fabien","family":"Delaspre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-2491","authenticated-orcid":false,"given":"Maria","family":"Pazos-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5291-9053","authenticated-orcid":false,"given":"Luiza","family":"Oliveira-Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-1340","authenticated-orcid":false,"given":"Cristina","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-1172","authenticated-orcid":false,"given":"Laura","family":"Rodr\u00edguez-Pascau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-8886","authenticated-orcid":false,"given":"Pilar","family":"Pizcueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Tamarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-7999","authenticated-orcid":false,"given":"Elisa","family":"Cabiscol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118553_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.838335","article-title":"Recent advances in the elucidation of frataxin biochemical function open novel perspectives for the treatment of Friedreich\u2019s ataxia","volume":"16","author":"Monfort","year":"2022","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2025.118553_bib2","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1073\/pnas.0804261105","article-title":"The MCK mouse heart model of Friedreich\u2019s ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation","volume":"105","author":"Whitnall","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118553_bib3","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2301004","article-title":"Tissue iron in friedreich ataxia","volume":"23","author":"Koeppen","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.biopha.2025.118553_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00018-023-05064-4","article-title":"Mitochondrial impairment, decreased sirtuin activity and protein acetylation in dorsal root ganglia in friedreich ataxia models","volume":"81","author":"Sanz-Alc\u00e1zar","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103339","article-title":"Deciphering the ferroptosis pathways in dorsal root ganglia of friedreich ataxia models. The role of LKB1\/AMPK, KEAP1, and GSK3\u03b2 in the impairment of the NRF2 response","volume":"76","author":"Sanz-Alc\u00e1zar","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118553_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddi042","article-title":"Friedreich ataxia: the oxidative stress paradox","volume":"14","author":"Seznec","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-021-04100-5","article-title":"Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a friedreich ataxia-like phenotype, and mitochondrial alterations","volume":"79","author":"Medina-Carbonero","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib8","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1093\/hmg\/ddx141","article-title":"Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans","volume":"26","author":"Jasoliya","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102038","article-title":"Mechanisms of impaired mitochondrial homeostasis and NAD+ metabolism in a model of mitochondrial heart disease exhibiting redox active iron accumulation","volume":"46","author":"Chiang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118553_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.118.252759","article-title":"Ferroptosis as a novel therapeutic target for Friedreich\u2019s ataxia","volume":"369","author":"Cotticelli","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.118553_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101483","article-title":"Identification of frataxin as a regulator of ferroptosis","volume":"32","author":"Du","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118553_bib12","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118553_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/iub.1616","article-title":"Iron and ferroptosis: a still ill-defined liaison","volume":"69","author":"Doll","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2025.118553_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205211","article-title":"Targeting NRF2 for the treatment of Friedreich\u2019s ataxia: a comparison among drugs","volume":"20","author":"Petrillo","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich\u2019s ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2025.118553_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich\u2019s ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118553_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2025.118553_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737175.2024.2310617","article-title":"Omaveloxolone for the treatment of friedreich ataxia: clinical trial results and practical considerations","volume":"24","author":"Lynch","year":"2024","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2025.118553_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/mds.30070","article-title":"Omaveloxolone for the treatment of friedreich ataxia: efficacy, safety, and future perspectives","volume":"40","author":"Naghipour","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118553_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.29286","article-title":"Efficacy of omaveloxolone in Friedreich\u2019s ataxia: delayed-start analysis of the MOXIe extension","volume":"38","author":"Lynch","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118553_bib21","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/hmg\/ddp183","article-title":"Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPAR\u03b3 pathway as a therapeutic target in Friedreich\u2019s ataxia","volume":"18","author":"Coppola","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010025","article-title":"PGC-1alpha down-regulation affects the antioxidant response in Friedreich\u2019s ataxia","volume":"5","author":"Marmolino","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118553_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ana.22526","article-title":"A gene expression phenotype in lymphocytes from friedreich ataxia patients","volume":"70","author":"Coppola","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2025.118553_bib24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/dmm.030502","article-title":"Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of friedreich ataxia","volume":"10","author":"Lin","year":"2017","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2025.118553_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020666","article-title":"Differential expression of PGC-1\u03b1 and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in friedreich ataxia fibroblasts","volume":"6","author":"Garc\u00eda-Gim\u00e9nez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118553_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.10.007","article-title":"Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis","volume":"191","author":"Kiaei","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.118553_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2025.118553_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) and neurodegenerative disorders","volume":"46","author":"Chen","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118553_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc0555","article-title":"The brain penetrant PPAR\u03b3 agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy","volume":"13","author":"Rodriguez-Pascau","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2025.118553_bib30","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200034","article-title":"Efficacy and safety of leriglitazone in patients with friedreich ataxia: a phase 2 double-blind, randomized controlled trial (FRAMES","volume":"8","author":"Pandolfo","year":"2022","journal-title":"Neurol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib31","first-page":"1","article-title":"Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children","author":"Traver","year":"2024","journal-title":"CPT Pharmacomet. Syst. Pharmacology1"},{"key":"10.1016\/j.biopha.2025.118553_bib32","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: leriglitazone as a promising candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105162","article-title":"PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of friedreich ataxia","volume":"148","author":"Rodr\u00edguez-Pascau","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2025.118553_bib34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/ddt576","article-title":"Apoptotic cell death and altered calcium homeostasis caused by frataxin depletion in dorsal root ganglia neurons can be prevented by BH4 domain of Bcl-x l protein","volume":"23","author":"Mincheva-Tasheva","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04622-5","article-title":"Mitochondrial modulation with leriglitazone as a potential treatment for rett syndrome","volume":"21","author":"Musokhranova","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.biopha.2025.118553_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11064-020-03020-3","article-title":"Calpain-inhibitors protect frataxin-deficient dorsal root ganglia neurons from loss of mitochondrial Na+\/Ca2+ exchanger, NCLX, and apoptosis","volume":"46","author":"Britti","year":"2021","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.biopha.2025.118553_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103419","article-title":"Mitochondrial dysfunction in neurons in Friedreich\u2019s ataxia","volume":"102","author":"Stepanova","year":"2020","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118553_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0960-8966(00)00108-5","article-title":"Mitochondrial impairment of human muscle in friedreich ataxia in vivo","volume":"10","author":"Vorgerd","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.biopha.2025.118553_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich\u2019s ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S0317167100006260","article-title":"Complex I and ATP content deficiency in lymphocytes from Friedreich\u2019s ataxia","volume":"36","author":"Heidari","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib41","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood.2020006987","article-title":"Defective palmitoylation of transferrin receptor triggers iron overload in friedreich ataxia fibroblasts","volume":"137","author":"Petit","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118553_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111551","article-title":"Ferroptosis in Friedreich\u2019s ataxia: a metal-induced neurodegenerative disease","volume":"10","author":"La Rosa","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118553_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/biom10111489","article-title":"An overview of the ferroptosis hallmarks in Friedreich\u2019s ataxia","volume":"10","author":"Turchi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118553_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101791","article-title":"The Nrf2 induction prevents ferroptosis in Friedreich\u2019s ataxia","volume":"38","author":"La Rosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118553_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952950","article-title":"Omaveloxolone inhibits IL-1\u03b2-induced chondrocyte apoptosis through the Nrf2\/ARE and NF-\u03baB signalling pathways in vitro and attenuates osteoarthritis in vivo","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118553_bib46","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s40120-025-00752-8","article-title":"Managing aminotransferase elevations in patients with friedreich ataxia treated with omaveloxolone: a review and expert opinion on use considerations","volume":"14","author":"Perlman","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.biopha.2025.118553_bib47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40120-025-00749-3","article-title":"Safety monitoring of omaveloxolone in friedreich ataxia: results from one year of clinical treatment","volume":"14","author":"Gunther","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.biopha.2025.118553_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.biopha.2025.118553_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118553_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2025.118553_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.27606","article-title":"Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in friedreich ataxia","volume":"34","author":"Ward","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2025.118553_bib52","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.3390\/ijms23116297","article-title":"Neuroinflammation in Friedreich\u2019s ataxia","volume":"23","author":"Apolloni","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/pharmaceutics15010202","article-title":"PPAR gamma agonist leriglitazone recovers alterations due to Pank2-deficiency in hiPS-derived astrocytes","volume":"15","author":"Santambrogio","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118553_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mas.21375","article-title":"Protein carbonylation: proteomics, specificity and relevance to aging","volume":"33","author":"Cabiscol","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.biopha.2025.118553_bib55","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddi214","article-title":"Frataxin interacts functionally with mitochondrial electron transport chain proteins","volume":"14","author":"Gonz\u00e1lez-Cabo","year":"2005","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-023-06320-y","article-title":"Human frataxin, the friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain","volume":"14","author":"Davide","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118553_bib57","doi-asserted-by":"crossref","first-page":"1359618","DOI":"10.3389\/fphar.2024.1359618","article-title":"S. Anjomani virmouni, emerging antioxidant therapies in Friedreich\u2019s ataxia","volume":"15","author":"Edzeamey","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118553_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118553_bib59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fgene.2019.00435","article-title":"Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways","volume":"10","author":"Gureev","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2025.118553_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118553_bib61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/ars.2012.4615","article-title":"p53 orchestrates the PGC-1\u03b1-mediated antioxidant response upon mild redox and metabolic imbalance","volume":"18","author":"Aquilano","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2025.118553_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1074\/jbc.M113.512483","article-title":"Peroxisome proliferator-activated receptor \u03b3 co-activator 1-\u03b1 as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in staphylococcus aureus sepsis","volume":"289","author":"Cherry","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118553_bib63","article-title":"PGC-1\u03b1 attenuates hydrogen peroxide-induced apoptotic cell death by upregulating Nrf-2 via GSK3\u03b2 inactivation mediated by activated p38 in HK-2 cells","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118553_bib64","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.ajpath.2017.08.021","article-title":"Molecular alterations in a mouse cardiac model of friedreich ataxia: an impaired Nrf2 response mediated via upregulation of Keap1 and activation of the Gsk3\u03b2 axis","volume":"187","author":"Anzovino","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2025.118553_bib65","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.bbagen.2013.04.006","article-title":"Punctum on two different transcription factors regulated by PGC-1\u03b1: nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2","volume":"1830","author":"Baldelli","year":"2013","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"key":"10.1016\/j.biopha.2025.118553_bib66","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3390\/ijms21103410","article-title":"Analysis of putative epigenetic regulatory elements in the FXN genomic locus","volume":"21","author":"Fern\u00e1ndez-Fr\u00edas","year":"2020","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:00:27Z","timestamp":1778504427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S0753332225007474"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118553","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leriglitazone improves iron homeostasis and ferroptotic markers in frataxin-deficient dorsal root ganglia neurons","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118553"}}